Anzeige
Mehr »
Dienstag, 19.05.2026 - Börsentäglich über 12.000 News
Während viele nur über AI sprechen, baut dieses Unternehmen bereits die Infrastruktur dafür
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 859034 | ISIN: US1266501006 | Ticker-Symbol: CVS
Tradegate
18.05.26 | 21:22
82,26 Euro
-0,34 % -0,28
1-Jahres-Chart
CVS HEALTH CORPORATION Chart 1 Jahr
5-Tage-Chart
CVS HEALTH CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
82,3082,6418.05.
82,3082,5418.05.
ACCESS Newswire
201 Leser
Artikel bewerten:
(1)

CVS Health: A Second Chance at Life Through Heart Transplant and Ongoing Care

WOONSOCKET, RI / ACCESS Newswire / May 18, 2026 / Originally published on CVS Health Company Newsroom

Key points

  • After smoking for decades and surviving two heart attacks, Bill Allison learned that he needed a heart transplant - and that making immediate, lasting life changes was essential.

  • Beyond dispensing medications, Bill's CVS Specialty pharmacist, Amy Guard, has supported him throughout his post transplant journey with ongoing medication counseling and encouragement.

  • "Listen to your doctors, pharmacists and care team," Bill says. "It's never too late to change and turn your life around. I would do it again in a heartbeat."

After surviving two heart attacks, Bill Allison received news that stopped him in his tracks.

Unless he made immediate, lasting lifestyle changes and received a heart transplant, his doctor told him, he had little time left to live.

At age 65, Bill - a military veteran and retired truck driver from Waxhaw, North Carolina - made a decision that would change the course of his life. A longtime smoker, he quit cold turkey and stopped drinking alcohol.

"I realized I wanted to be around longer for my family and continue doing the things I love," Bill says. "I knew I needed to change."

While waiting for a donor heart, Bill focused on staying healthy and strong enough for surgery, knowing each day mattered.

Several months later, that opportunity arrived. In 2009, Bill underwent a successful heart transplant.

Today, at 81, Bill says he feels better than ever. He spends his days working on his more than two acre property, caring for his animals, and - most importantly - enjoying time with his wife of nearly 50 years, their children, and grandchildren.

"It's never too late for a second chance at life," he says.

The importance of long-term care

Bill is grateful to his organ donor and credits the many members of his health care team - physicians, surgeons, nurses, and pharmacists - who have supported him throughout his journey.

"I take a handful of prescription pills in the morning and a handful at night," Bill says. "And I go for regular checkups and monitoring with my doctor."

Those medications, including immunosuppressants, play a critical role in preventing organ rejection. For heart transplant recipients, medication adherence and ongoing monitoring are lifelong commitments essential to protecting the donated heart.

To help manage his ongoing care, Bill receives his specialty medications through CVS Specialty, with the option for convenient pickup at a nearby CVS Pharmacy-helping ensure dependable access to the life sustaining medications he has relied on over the years.

As part of that support, his CVS Specialty pharmacist, Amy Guard, PharmD, has been a consistent member of his care team, providing medication counseling and guidance to help him stay on track.

"Bill is remarkably resilient and motivated," Amy says. "Adhering to his medication regimen and maintaining a healthy lifestyle have been major factors in his long term success."

A message of hope - and the power of organ donation

Looking back, Bill says building a strong care support team - and listening to them - made all the difference.

He also hopes his story inspires others to consider organ donation.

"Organ donors are heroes," he says. "They can save lives and give people like me a future."

For anyone facing major health challenges, his advice is simple:

"Listen to your doctors, pharmacists, and care team," Bill says. "It's never too late to change and turn your life around. I would do it again in a heartbeat."

Find more stories and multimedia from CVS Health at 3blmedia.com.

Contact Info:
Spokesperson: CVS Health
Website: https://www.3blmedia.com/profiles/cvs-health
Email: info@3blmedia.com

SOURCE: CVS Health



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cvs-health-a-second-chance-at-life-through-heart-transplant-and-ongoi-1167715

© 2026 ACCESS Newswire
Vergessen Sie Gold, Silber und Öl: Nächste Megarallye startet!
Die Märkte feiern neue Rekorde – doch im Hintergrund braut sich eine Entwicklung zusammen, die alles verändern könnte. Die anhaltende Sperrung der Straße von Hormus sorgt laut IEA für eine der größten Energiekrisen aller Zeiten. Gleichzeitig schießen die Preise für Düngemittel und Agrarrohstoffe bereits nach oben.

Damit droht ein perfekter Sturm: steigende Energiepreise, explodierende Produktionskosten und ein möglicher Super-El-Nino, der weltweit Ernten gefährdet. Erste Auswirkungen sind längst sichtbar – Weizen, Soja und Kakao verteuern sich deutlich, während Lebensmittelpreise vor dem nächsten Sprung stehen könnten.

Für Anleger bedeutet das nicht nur Risiken, sondern enorme Chancen. Denn während klassische Märkte unter Druck geraten könnten, entsteht auf den Feldern und Plantagen der nächste große Rohstoffzyklus. Wer sich jetzt richtig positioniert, kann von einer Entwicklung profitieren, die weit über Öl und Metalle hinausgeht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die besonders aussichtsreich sind, um von diesem Trend zu profitieren – solide positioniert, strategisch relevant und mit erheblichem Aufwärtspotenzial.



Jetzt den kostenlosen Report sichern – bevor der Agrar-Boom voll durchschlägt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.